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Abstract
Background: Results from cohort studies evaluating the severity of respiratory viral co-infections are conflicting. We
conducted a systematic review and meta-analysis to assess the clinical severity of viral co-infections as compared to single
viral respiratory infections.
Methods: We searched electronic databases and other sources for studies published up to January 28, 2013. We included
observational studies on inpatients with respiratory illnesses comparing the clinical severity of viral co-infections to single
viral infections as detected by molecular assays. The primary outcome reflecting clinical disease severity was length of
hospital stay (LOS). A random-effects model was used to conduct the meta-analyses.
Results: Twenty-one studies involving 4,280 patients were included. The overall quality of evidence applying the GRADE
approach ranged from moderate for oxygen requirements to low for all other outcomes. No significant differences in length
of hospital stay (LOS) (mean difference (MD) 20.20 days, 95% CI 20.94, 0.53, p = 0.59), or mortality (RR 2.44, 95% CI 0.86,
6.91, p = 0.09) were documented in subjects with viral co-infections compared to those with a single viral infection. There
was no evidence for differences in effects across age subgroups in post hoc analyses with the exception of the higher
mortality in preschool children (RR 9.82, 95% CI 3.09, 31.20, p,0.001) with viral co-infection as compared to other age
groups (I2 for subgroup analysis 64%, p = 0.04).
Conclusions: No differences in clinical disease severity between viral co-infections and single respiratory infections were
documented. The suggested increased risk of mortality observed amongst children with viral co-infections requires further
investigation.
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Introduction
Respiratory viral co-infections, defined as the detection of more
than one viral pathogen in the same sample are detected in up to
30% of children with an acute respiratory tract infection (ARI)
[1,2]. While respiratory syncytial virus (RSV), influenza (INF) and
human metapneumovirus (hMPV) have been mainly identified
amongst children with single viral infections, other viruses
including adenovirus (ADV), coronavirus and human rhinovirus
(HRV) have been mainly reported amongst children with viral co-
infections [2].
A better understanding of the effect of viral co-infections on
disease severity is needed, considering the associated burden of
respiratory viral infections. No systematic review on this topic has
been published to date. A non-systematic and narrative review
summarized eight cohort studies using either conventional
techniques or molecular assays for detection of viruses [3]. The
authors reported increased hospitalization rates among patients
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with viral co-infections compared to single respiratory viral
infections (46.3% vs. 21.7%, p,0.01) suggesting increased severity
with viral co-infections. These findings were limited, however, by
including heterogeneous patient-populations (adults and children,
with or without underlying comorbid conditions) and by
combining studies using conventional as well as molecular
methods for viral detection and by a potentially biased selection
of the included studies.
We conducted a systematic review and meta-analysis to assess
the association between viral status (i.e., single viral versus viral co-
infection) as detected by molecular assays and the severity of
clinical disease in children as well as adults hospitalized with an
ARI. A systematic and comprehensive review of available
literature was performed by using a transparent and systematic
approach in searching, assessing and summarizing all the available
evidence on this topic. We also aimed to explore whether
heterogeneity in results was in part explained by different patient
populations through subgroups analyses.
Materials and Methods
This meta-analysis was performed in accordance to a protocol
developed a priori. We reported methods and findings according to
PRISMA guidelines [4].
Eligibility criteria
We included observational studies reporting on patients of any
age admitted to hospital with an acute respiratory viral illness
documented by molecular assays and comparing clinical disease
severity between patients with viral co-infections to those with a
single viral respiratory illness, as defined below. We excluded
studies which only reported data on outpatients, used multiple
diagnostic techniques for viral detection, or included viral-
bacterial co-infections.
Primary and secondary outcomes
The primary outcome reflecting clinical disease severity was
length of hospital stay (LOS). This outcome is commonly used as a
proxy of disease severity as it is thought to reflect well the duration
of illness and is highly associated with health costs [5]. We selected
a priori four secondary outcomes, which included admission to the
intensive care unit, need for mechanical ventilation, oxygen
requirements and mortality.
Literature search and data extraction
We searched MEDLINE, EMBASE, the Cochrane Central
Register of Controlled Trials, CINAHL and HTA (Health
Technology Assessment) for relevant studies published any year
or in any language up to January 28, 2013. The search strategy
was created in collaboration with a librarian (Appendix S1 in File
S1). We also searched conference proceedings from 2008 to 2013
using the Web of Science and Open-SIGLE databases, and we
searched Clinical trial registries (clinicaltrials.gov) and Current
Controlled Trials (controlled-trials.com). We also reviewed refer-
ence lists of key articles.
Two reviewers (M.E.S and S.A.A) independently screened the
titles and abstracts. Potentially relevant full text articles were then
screened independently for eligibility. Agreement was calculated
using Cohen’s kappa coefficient [6]. Disagreements were resolved
by consensus discussion or third-party adjudication (A.M). Authors
were contacted for additional information when required.
Reviewers independently abstracted data using a standardized
form.
Assessment of risk of bias and overall quality evidence
Two reviewers who had content and methodological expertise
independently and in duplicate assessed and graded the risk of bias
for included studies with a previously used, adapted version [7] of
the Newcastle-Ottawa scale (NOS), which has been described
elsewhere [8]. The maximum score was 8, the minimum score 0. It
was decided a priori that a score of 7 was reflective of high
methodological quality (e.g., low risk of bias), a score of 5 or 6
indicated moderate quality and a score of 4 or less indicated low
quality (e.g., high risk of bias). Assessment was conducted by both
reviewers independently. Publication bias was assessed by visual
inspection of funnel plot.
The quality of evidence was independently assessed for each
outcome by 2 reviewers according to the GRADE framework
(Grading of Recommendations Assessment, Development and
Evaluation) [9]. Disagreements were resolved as described above.
Because randomized controlled trials addressing this research
question are not feasible, observational studies were considered as
the highest quality of evidence. The GRADE profiler (GRADE-
pro) [10] was used to present summary tables (Table 1).
Statistical analysis
Statistical analysis was performed using Review Manager 5.1
(Cochrane Collaboration) [11]. Random-effects models were used
to obtain summary estimates for all outcomes as heterogeneity
across studies was expected. For continuous outcomes, we used the
inverse variance method to combine results. If means and standard
deviations were not reported and remained unavailable after
contacting authors, the median was used to reflect the mean and
the standard deviation calculated by dividing the interquartile
range (IQR) by 1.35 [12]. For dichotomous outcomes, the risk
ratio with its 95% confidence interval (CI) was reported.
Heterogeneity was evaluated using the I2 statistic.
Subgroup Analysis
When substantial heterogeneity was found (I2$40%), a priori
defined subgroup analyses were performed which included age (,
18 years versus $18 years), the nature of the underlying
respiratory illness (ARIs, bronchiolitis, radiologically confirmed
community acquired pneumonia (CAP), respectively), the presence
of underlying co-morbidities, the impact of overall viral infections
versus specific viral pathogens, and high versus low risk of bias in
the included studies as defined above. Interaction tests for
subgroup differences were conducted using the Chi-square and
I2 statistic. Subgroup credibility was examined using the criteria
described by Sun and colleagues [13]. We made a post-hoc
stratified analysis of ‘‘children’’ by age subgroups based on data
availability in the abstracted studies (infants 0–23 months of age,
preschool children 0–59 months of age and children 0–17 years
old).
Sensitivity analysis
We also evaluated the robustness of the pooled estimate related
to the potential differences in disease severity described for
infections with more pathogenic viruses such as INF, RSV or
hMPV. Therefore we performed a post hoc sensitivity analysis in
which only studies involving these viral infections were included
[1],[2].
Results
We screened the titles and abstracts of 1,017 unique records
identified through our literature search. Of these, 37 were assessed
for eligibility in full text, 21 studies met inclusion criteria (all cohort
Respiratory Viral Co-Infections
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studies) of which 16 (76.1%) provided data for quantitative analysis
(Figure 1). The Kappa for agreement between the reviewers was
0.96 for both screening of titles/abstracts and of full text articles.
Of the 13 authors contacted, eleven [14] [15] [16] [17] [18] [19]
[20] [21] [22] [23] [24] provided additional information on
outcomes of interest. No additional sources were identified in the
grey literature search.
Study Characteristics
The 21 studies included reported on 4,280 patients ranging
from 1 to 65 years of age (Table 2). Seventeen (80.9%) studies were
exclusively conducted in children ,18 years, two studies were
conducted in adults and the remaining two in adults and children.
Any ARI was assessed in nine studies; bronchiolitis, bronchitis and
CAP in three studies each; and acute respiratory wheezing and
influenza-like illness (ILI) in one study each. One study did not
specify the type of respiratory illness.
Risk of Bias and Overall Quality of Evidence
Applying the adapted NOS, the studies achieved a median of 4
out of 8 points (IQR 3–4) (Table 3). The overall quality of
evidence applying the GRADE approach ranged from moderate
for oxygen requirements to low for all other outcomes (Table 1).
One of the concerns involved serious indirectness for the LOS and
the need for mechanical ventilation. For these outcomes, the
majority of studies did not primarily focus on the comparison of
LOS or the need for mechanical ventilation between single vs viral
co-infections. A funnel plot did not suggest any publication bias for
the primary outcome (Appendix S2 in File S1). Also, publication
bias was judged to be minimal because of our extensive literature
search, and the presence of both positive and negative studies.
Relevant subgroup analyses were conducted for the length of
hospital stay and mortality as stated under these outcomes.
Table 1. Summary of findings for the severity of clinical disease of children with viral co-infections versus single respiratory acute
illnesses.
Outcomes Illustrative comparative risks (95% CI) Relative effect (95%)
N of Participants
(studies)
Quality of the
evidence (GRADE)
Assumed risk
(Control group)
Corresponding risk (with viral
co-infections)
Length of hospital stay 20.20 days (20.94 to 0.53) 2153 (11) lowa,b,c,d
Oxygen requirements 319 per 1000 316 per 1000 (249 to 402 per 1000) RR 0.99 (0.78 to 1.26) 1926 (8) moderatee,f,g,h
ICU admission 158 per 1000 114 per 1000 (63 to 202 per 1000) RR 0.72 (0.40 to 1.28) 1093 (7) lowi,j,k,l
Mortality 74 per 1000 181 per 1000 (64 to 511) RR 2.44 (0.86 to 6.91) 796 (5) lowm,n,o
Mechanical Ventilation 472 per 1000 746 per 1000 (288 to 1000) RR 1.58 (0.61 to 4.13) 285 (3) lowp,q,r,s
Note: N = number, CI = confidence interval, GRADE [31] =Grading of Recommendations Assessment, Development and Evaluation, RR = risk ratio, SD = standard
deviation, CI = confidence interval.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
aSerious design limitations: Eight [15,19,21], [32], [22], [35], [23] [24] of the eleven studies had serious design limitations including the absence of notification or
adjustment for important prognostic factors and the absence of evidence provided on the similarity of co-interventions between both groups.
bSerious Inconsistency: There was high statistical heterogeneity (I2= 72%, p,0.001), which was not explained on further subgroup analysis.
cSerious indirectness of the comparison: Only three [33] [19] [24] of the eleven studies focused primarily on the comparison of disease severity between single vs viral
co-infections.
dNo serious imprecision: The assumption of our a priori hypothesis of no difference was met. Cumulative sample size was appropriate. The optimal information size to
detect a 1-day difference in LOS (alpha 0.05, 90% power) assuming a mean of 4 days (standard deviation 2 days) was 85 subjects per group. The number of subject
exceeded this number. The 95% CI interval was narrow and it did not cross the minimally important difference of 1 day although it included the null effect.
eSerious limitations in design. All the eight studies had serious design limitations including the absence of notification or adjustment for important prognostic factors
and the absence of evidence provided on the similarity of co-interventions between both groups.
fModerate inconsistency: There was moderate statistical heterogeneity (I2 = 47%, p = 0.06), which was not explained on further subgroup analysis.
gNo serious indirectness: Three [21] [15] [23] of the eight studies included did not focus primarily on the comparison of disease severity between single vs viral co-
infections.
hNo serious imprecision: Cumulative sample size was appropriate. The 95% CI interval was narrow and included the null effect as predicted in our a priori hypothesis.
iSerious design limitations: All but one [34] of the seven studies of had very serious design limitations including the absence of notification or adjustment for important
prognostic factors and the absence of evidence provided on the similarity of co-interventions between both groups.
jSerious inconsistency: There was high statistical heterogeneity (I2 = 53%, p = 0.05), which was not explained on further subgroup analysis.
kNo serious indirectness: Three [21] [23] [24] of the seven studies included did not focus primarily on the comparison of disease severity between single vs viral co-
infections.
lNo serious imprecision: Cumulative sample size was appropriate. The 95% CI interval was narrow and included the null effect as predicted in our a priori hypothesis.
mSerious design limitation: all five studies had serious design limitations including the absence of notification or adjustment for important prognostic factors and the
absence of evidence provided on the similarity of co-interventions between both groups.
nSerious indirectness: Two [16] [15] of the five studies included did not focus primarily on the comparison of disease severity between single vs viral co-infections.
oThere was no serious imprecision: Adequate cumulative sample size, the 95%CI included the null effect as predicted in our a priori hypothesis although the 95%CI were
wide.
pSerious design limitations: Two of the three studies [17] [23] had serious design limitations including the absence of notification or adjustment for important
prognostic factors and the absence of evidence provided on the similarity of co-interventions between both groups.
qSerious Inconsistency: There was high statistical heterogeneity (I2= 75%, p = 0.05), which was not explained on further subgroup analysis.
rSerious indirectness as two [34] [23] of the three studies did not primarily focus on the comparison between single vs viral co-infections.
sSerious imprecision: Although the a priori hypothesis of no effect was met, serious imprecision was attributed to the inadequate cumulative sample size and large CI.
doi:10.1371/journal.pone.0099392.t001
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Primary outcome: length of hospital stay (LOS)
Eleven studies involving 2,531 patients reported the LOS and
were pooled in meta-analysis. There was no significant difference
in length of admission between groups (mean difference (MD) 2
0.20 days, 95% CI 20.94, 0.53, p = 0.59). (Figure 2) Because of
significant heterogeneity (I2 = 73%, p,0.001), inconsistency and
indirectness of the comparison documented for this outcome, the
quality of evidence was downgraded to low.
Some of the heterogeneity could be explained by the type of
respiratory illnesses: subgroup analyses showed a significantly
shorter LOS stay among children with bronchiolitis and viral co-
infection (MD20.83 days; 95%CI21.42,20.24; p = 0.006) while
no differences between viral groups were observed amongst
subjects with ARI, although the interaction test was not significant
(p = 0.10) (Appendix S3 in File S1). In post-hoc age subgroup
analyses, the effect was similar across all age subgroups (I2 for
subgroup analysis 0%, p= 0.77) (Figure 2).
Sensitivity analysis including only studies on viruses with a
higher pathogenic potential (RSV A, RSV B, INF A, INF B, PIV
and hMPV) revealed similar results (MD 0.24 days, 20.64, 1.12,
p = 0.59) (Appendix S4 in File S1).
Figure 1. Selection of studies for the qualitative and quantitative analyses. n=number.
doi:10.1371/journal.pone.0099392.g001
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Secondary outcomes
Five studies provided data for meta-analysis on mortality
including a total of 1,794 patients. There was a trend of higher
mortality rates among patients with viral co-infections (RR 2.44,
95% CI 0.86, 6.91, p = 0.09) with a high degree of heterogeneity
(I2=53%). Although there was a significant subgroup effect (I2 for
subgroup analysis = 63%, p= 0.04) with higher mortality in
preschool children with viral co-infections (RR 9.82, 95% CI
3.09–31.2, p,0.001), this was based on only one study, which was
found to be at a high risk of bias (Figure 3).
Seven studies involving 893 patients reported the proportion of
patients admitted to the ICU. No difference were observed
(relative risk (RR) 0.72, 95% CI 0.40, 1.28, p = 0.26) with high
heterogeneity (I2=53%). Also, there were no differences between
age subgroups (I2 for subgroup analysis = 0%, p= 0.50) (Appendix
S5 in File S1).
Only three studies including 515 patients provided detailed data
on the need for mechanical ventilation. Again, there was no
significant difference between groups (RR 1.58, 95% CI 0.61,
4.13, p = 0.35) but heterogeneity was high (I2=75%). Although
there was a statistically significant difference in age group effects (I2
for subgroup analysis = 74%, p= 0.05), this was based on only two
studies, one in infants with more benign outcomes (RR 1.01, 95%
CI 0.57–1.78, p = 0.98) compared to one study in a mixed
population (RR 2.69, 95% CI 1.22–5.94, p = 0.01) (Appendix S6
in File S1).
Eight studies involving 2,294 patients provided data for the
meta-analysis on oxygen requirement as an outcome. No
difference was found between both groups with high heterogeneity
(RR 0.99, 95% CI 0.78, 1.26, p = 0.94, I2=47%). In post-hoc age
subgroup analysis, the effect was similar across all age subgroups
(for subgroup analysis = 48.5%, p= 0.12) (Appendix S7 in File S1).
Discussion
While we found no overall differences in clinical severity
between patients admitted with single viral respiratory illnesses
and those with viral co-infections, preschool children with co-
infections might be at increased risk of death. Although our
Figure 2. Meta-analysis of the length of stay, by age groups (infants, preschool children, children, adults and adults and children)
between patients with viral coinfections and single viral infections. A value less than zero indicates a shorter length of hospital stay (number
of days). in patients co-infected with more than virus (favors co-infection). CI = confidence interval, df = degrees of freedom. Age groups: Infants 0–23
months of age, Preschool children 0–59 months of age and Children 0–17 years old.
doi:10.1371/journal.pone.0099392.g002
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findings were consistent across outcomes, they were tempered by
significant heterogeneity.
We found no significant difference between groups with respect
to the LOS, admission to the ICU, the need for mechanical
ventilation and oxygen requirements as suggested in the majority
of recently published studies [25]. However, while viral co-
infection had little impact on mortality in one of these studies
including adult patients admitted to an intensive care unit (ICU) in
Australia [25] with pH1N1 infection, co-infection with seasonal
influenza A and influenza B viruses was associated with a
significant increase in risk of ICU admission and death in another
study [26]. These divergent findings may be explained by
differences in age groups of the population studied, the range of
illness severity and the proportion of patients with comorbid
conditions, seasonal differences regarding circulating respiratory
viruses and performance of different molecular panels used [27].
We found a significantly higher risk of death in children with
viral co-infections when compared to single infections. The single
study in adults [16], however, did not find a difference, while the
effect in children was primarily driven by one study [15]. Of note,
this statement was not supported by findings across other
outcomes, and, in addition, there was moderate statistical
heterogeneity and the interaction test was not significant thus
limiting the conclusions from this subgroup analysis.
There was no evidence for differences in effects across age
subgroups in post hoc analyses with the exception of the higher
mortality in preschool children as compared to other age groups.
One may have expected differences in how co-infections affect
patient outcomes based on a recent experimental study assessing
the course of infection of young versus old mice which were
infected with RSV and/or HMPV. They observed that the
elevation in TNF-a and NF-kB was influenced by the age of the
mice, the type of virus (i.e RSV and hMPV) and single versus co-
infection (28). While these finding suggest that age may influence
the severity of co- versus single virus infection, the published
clinical evidence summarized in this systematic review could not
corroborate this assumption. Future studies conducted among
adults and children, with defined age subgroups, which will
Figure 3. Meta-analysis of mortality between patients with viral co-infections and single viral infections by age groups (infants,
preschool children, children, adults and adults and children). A value higher than one indicates a higher mortality in patients co-infected
with more than virus (favors single infection). CI = confidence interval, df = degrees of freedom. Age groups: Infants 0–23 months of age, Preschool
children 0–59 months of age and Children 0–17 years old.
doi:10.1371/journal.pone.0099392.g003
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incorporate measures of TNF-a and NF-kB levels may better
support findings observed in experimental studies.
While the pathogenicity of certain viruses such as RSV and INF
is well established, uncertainty remains about the virulence of
HBoV, coronaviruses and HRV. Their common detection in co-
infections with other viruses and from asymptomatic subjects may
result from the increased sensitivity of molecular assays [2]. This is
supported by the significantly lower viral loads of these viruses
when detected in co-infection with INF or RSV [28]. The
increased severity of viral co-infections observed in previous
studies using conventional techniques [3] possibly resulted from
limited viral detection, which was restricted to potentially more
pathogenic viruses such as RSV, INF or hMPV. However, a post
hoc sensitivity analysis including viral co-infections with these
viruses only supported the robustness of the above findings.
The mechanisms of disease virulence in co-infections are not
clearly understood. They may result from direct interactions of
viral genes or indirect interactions resulting from alterations in the
host-environment or immunological interactions [29]. Thus,
different pathogenic mechanisms may be triggered by different
viruses, which may potentiate or inhibit each other’s effects. As
such, certain pairing of viruses may be more clinically relevant
than others. Yet, viral-viral interaction is poorly understood.
Strengths and limitations
The strengths of this systematic review include a systematic,
protocol-driven and comprehensive review with extensive litera-
ture search, minimal evidence for publication bias and successful
attempts to contact authors. In addition, rigorous assessment of
eligibility ensured high reliability of the results. All subgroups
analyses, with the exception of age subgroups analyses, were
defined a priori and post hoc sensitivity analyses confirmed
robustness of the results. Finally a rigorous use of the GRADE
approach ensured a transparent and comprehensive approach to
evaluate overall quality of the studies. Limitations predominantly
relate to the high risk of bias of the included studies. Of note, no
studies reported risk estimates adjusted for important prognostic
factors such as underlying co-morbidities or bacterial co-infections.
Although the influence of comorbid conditions was partially
addressed in our subgroup analysis, an insufficient number of
studies precluded some subgroup analyses we planned a priori.
Respiratory viral infections are known to predispose to secondary
bacterial pulmonary infections, and thus can result in substantial
confounding [30]. Finally, age subgroup analyses were conducted
post hoc. Based on the data available we were able to provide
subgroups as defined above, but the data did not allow us to
specify other, better discriminating age groups.
Conclusions
In conclusion, we found no convincing evidence that patients
admitted with viral co-infections are at higher risk for increased
disease severity than patients presenting with single respiratory
viral infections –with the potential exception of mortality in
preschool children of,5 years of age. Large, rigorously conducted
studies including multivariable analyses adjusting for important
confounders are lacking, and thus, new studies would be very likely
to significantly change our overall assessment. Prospective
longitudinal studies, which will focus on objective outcomes and
include serial respiratory sampling for viruses and bacteria may
lead to a better understanding of the clinical significance of
polymicrobial acute respiratory infections.
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